Boehringer Ingelheim Prevails in EU Appellate Battle to Defend Diabetes Treatment Patent

In a critical ruling in the sphere of pharmaceutical patents, Germany’s Boehringer Ingelheim has successfully defended its patent on a diabetes medication. Accrediting the treatment as innovative and new, a European appellate board overturned eight oppositions, allowing the patent to stand. The drug in question is of significant importance to patients with moderately damaged kidneys,…

Read More

Fitness Transformations: Enhancing Professional Performance Through Exercise

As the boundaries between work and life continue to blur amidst the remote working trend, a growing chorus of professionals, including lawyers, vouch for the immense role of physical fitness in enhancing their professional performance. An insightful personal narrative penned by Christopher Ward details how his Peloton bicycling regimen transformed not just his physical health,…

Read More

Upper Deck Settles Lawsuit Over Unauthorized Michael Jordan Photo Usage

Trading card company Upper Deck and the owner of a renowned 1988 photograph depicting NBA superstar Michael Jordan have reached a settlement regarding a federal lawsuit in California. The legal action claimed that Upper Deck had made millions leveraging the photo without securing the necessary permissions. The now-settled lawsuit had levelled serious allegations against the…

Read More

Frost Brown Todd Bolsters Intellectual Property Practice with New Los Angeles Partners

Frost Brown Todd, a prominent U.S. law firm, has strengthened its intellectual property (IP) practice with the addition of partners Anne Wang and Lauren Schneider to their Los Angeles office. According to Bloomberg Law, the firm announced this development on Wednesday. Wang brings to the table her proficiency in trademark matters, patent prosecutions, infringement actions,…

Read More

EU AI Legislation: Bridging Intellectual Property Rights and Potential Litigation Uptick

The European Union’s new artificial intelligence legislation, a landmark in the field of intellectual property rights, introduces new rules that might create a bridge between concerned rights holders and AI pioneers. However, the jury is still out on the actual efficiency of these regulations. A foresight into this issue suggests that the revelation rules could…

Read More

Indiana and West Virginia Adopt New Legal Restrictions Amid Litigation Funding Concerns

In a move apparently driven by caution over potentially adversarial foreign interference via third-party litigation funding, the U.S. Chamber of Commerce has successfully advocated for new legal restrictions in Indiana and West Virginia. As a result, both states have now passed bills imposing limitations on such funding mechanisms. The U.S. Chamber of Commerce, representative of…

Read More

Law360 Unveils 2024 Editorial Advisory Boards to Shape Corporate Legal News

Law360 has recently announced the appointment of members to its 2024 Editorial Advisory Boards. Essential in framing the direction of its corporate legal news agenda, the new Editorial Advisory Board’s formation continues Law360’s commitment to delivering insights into the wider sector for their readership. The specifics regarding the newly appointed members and the precise structure…

Read More

Wise Counters Trademark Allegations from Tech Rival WithWise in High Court

Payments company Wise has made a strong counter response to a recently filed counterclaim from software corporation WithWise, calling on the High Court to dismiss their rival’s allegations asserting that Wise’s trademark is excessively wide-ranging and utilized unfairly as a legal stratagem. WithWise has alleged that Wise’s trademark is invalid, reasoning that the latter’s use…

Read More

ByteDance’s IP Portfolio Adds Complexity to Potential TikTok Divestiture

ByteDance Ltd., the parent company behind the popular social media application TikTok, has amassed a large intellectual property portfolio that could complicate any enforced divestiture of the platform, legal experts have emphasized. The potential implications of this IP portfolio have surfaced amid discussions on a forced TikTok sale. It was suggested that these IP rights…

Read More

France Fines Google €250 Million for Breaching Media Copyright Laws

Google, the tech titan, has reportedly been fined €250 million ($271 million) by France’s competition authority. The hefty financial penalty comes in response to allegations that the company made use of content provided by news agencies without duly notifying them or offering compensation for the content utilized. This financial penalty marks a crucial development, signaling…

Read More

Schumer and McConnell Clash Over Judicial Conference’s Revised Case Assignment Policy

Senate Majority Leader Chuck Schumer voiced praise on Tuesday for the Judicial Conference’s revised policy on random case assignments, as a safeguard to thwart litigants from judge-shopping. Schumer asserted that Senate Minority Leader Mitch McConnell is contesting the policy because it would pose difficulties for staunch right-wing partisans to manipulate court proceedings to their advantage….

Read More

USPTO Directive Aims to Enhance Clarity in Means-Plus-Function Patent Evaluations

In an effort to streamline and increase the efficacy of the patent approval process, the U.S. Patent and Trademark Office (USPTO) recently issued a directive to patent examiners. The primary motive of this instruction was to promote a “consistent and clear analyses” during evaluation of patent applications, particularly ones containing means-plus-function claims. The USPTO believes…

Read More

Apple Triumphs in Decade-Long Anti-Poaching Derivative Suit Saga

In a decade-long legal saga regarding anti-poaching agreements, tech heavyweight, Apple, has prevailed. A proposed class derivative suit brought against Apple by a shareholder has been definitively dismissed by a California federal judge. The allegations central to this case accused Apple’s upper management of precipitating business losses through the establishment of unlawful anti-poaching deals with…

Read More

Acorda Pharmaceuticals Seeks $66M as Federal Circuit Hears Multiple Sclerosis Drug Patent Appeal

In a recent patent battle, Acorda Pharmaceuticals appealed to the Federal Circuit, urging them to award the company an additional $66 million over the already secured $16.5 million it won in an arbitration case against Alkermes, a Dublin-based biopharmaceutical company. The dispute lays its foundation in a licensing disagreement revolving around a drug intended for…

Read More